These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20382026)

  • 21. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
    Li F; Ma C; Hu Y; Wang Y; Wang J
    ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.
    Duque MD; Ma C; Torres E; Wang J; Naesens L; Juárez-Jiménez J; Camps P; Luque FJ; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
    J Med Chem; 2011 Apr; 54(8):2646-57. PubMed ID: 21466220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure and mechanism of the M2 proton channel of influenza A virus.
    Schnell JR; Chou JJ
    Nature; 2008 Jan; 451(7178):591-5. PubMed ID: 18235503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of the drug-resistant S31N influenza M2 proton channel.
    Thomaston JL; DeGrado WF
    Protein Sci; 2016 Aug; 25(8):1551-4. PubMed ID: 27082171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane-dependent effects of a cytoplasmic helix on the structure and drug binding of the influenza virus M2 protein.
    Cady S; Wang T; Hong M
    J Am Chem Soc; 2011 Aug; 133(30):11572-9. PubMed ID: 21661724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel.
    Balannik V; Carnevale V; Fiorin G; Levine BG; Lamb RA; Klein ML; Degrado WF; Pinto LH
    Biochemistry; 2010 Feb; 49(4):696-708. PubMed ID: 20028125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutron diffraction reveals the site of amantadine blockade in the influenza A M2 ion channel.
    Duff KC; Gilchrist PJ; Saxena AM; Bradshaw JP
    Virology; 1994 Jul; 202(1):287-93. PubMed ID: 7516598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine.
    Wharton SA; Belshe RB; Skehel JJ; Hay AJ
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():945-8. PubMed ID: 8151308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.
    Jalily PH; Eldstrom J; Miller SC; Kwan DC; Tai SS; Chou D; Niikura M; Tietjen I; Fedida D
    Mol Pharmacol; 2016 Aug; 90(2):80-95. PubMed ID: 27193582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding and Proton Blockage by Amantadine Variants of the Influenza M2
    Tzitzoglaki C; Wright A; Freudenberger K; Hoffmann A; Tietjen I; Stylianakis I; Kolarov F; Fedida D; Schmidtke M; Gauglitz G; Cross TA; Kolocouris A
    J Med Chem; 2017 Mar; 60(5):1716-1733. PubMed ID: 28107633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.
    Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of inhibition of M2 ion channel activity by BL-1743, an inhibitor of influenza A virus.
    Tu Q; Pinto LH; Luo G; Shaughnessy MA; Mullaney D; Kurtz S; Krystal M; Lamb RA
    J Virol; 1996 Jul; 70(7):4246-52. PubMed ID: 8676445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Design of an Efficient Inhibitor for the Influenza A Virus M2 Ion Channel].
    Vorobjev YN
    Mol Biol (Mosk); 2020; 54(2):321-332. PubMed ID: 32392203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and function of the influenza A M2 proton channel.
    Cady SD; Luo W; Hu F; Hong M
    Biochemistry; 2009 Aug; 48(31):7356-64. PubMed ID: 19601584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
    Gu RX; Liu LA; Wei DQ
    Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational heterogeneity of the M2 proton channel and a structural model for channel activation.
    Yi M; Cross TA; Zhou HX
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13311-6. PubMed ID: 19633188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in computational studies on influenza a virus M2 proton channel.
    Wang JF; Chou KC
    Mini Rev Med Chem; 2012 Sep; 12(10):971-8. PubMed ID: 22420575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel spirothiazamenthane inhibitors of the influenza A M2 proton channel.
    Arns S; Balgi AD; Shimizu Y; Pfeifer TA; Kumar N; Shidmoossavee FS; Sun S; Tai SS; Agafitei O; Jaquith JB; Bourque E; Niikura M; Roberge M
    Eur J Med Chem; 2016 Sep; 120():64-73. PubMed ID: 27187859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza A M2 Inhibitor Binding Understood through Mechanisms of Excess Proton Stabilization and Channel Dynamics.
    Watkins LC; DeGrado WF; Voth GA
    J Am Chem Soc; 2020 Oct; 142(41):17425-17433. PubMed ID: 32933245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.